Vision-X
Natural health product licensed in Canada
- Licence holder
- Dr. Ma's Laboratories Inc.
- NPN or DIN-HM
- 80139449
- Status
- Active licence
- Licence date
- 24 March 2025
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bêta-carotene-3,3'-diol totalement trans- Source : Zeaxanthin | 2.5 mg | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone Source : Quercétine | 30 mg | Not calculated |
| Bêta-carotène Source : bêta-carotène | 1,500 Microgrammes | Not calculated |
| (3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol Source : Lutéine | 20 mg | Not calculated |
| (3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 20 mg | Not calculated |
| Zinc Source : Citrate de zinc | 7 mg | 7,000 µg |
| Sélénium Source : Sélénométhionine | 50 Microgrammes | Not calculated |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 27.1755 mg AT | Not calculated |
| Vaccinium myrtillus Source : Vaccinium myrtillus - Fruit Extract : Matériel brut sec Extraction ratio : 36:1 Dry plant equivalent : 1,800 mg | 50 mg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Potency : 85 % Oligomeric proanthocyanidins | 35 mg | Not calculated |
| Huile de poisson Potency : 50 % Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Potency : 50 % Docosapentaenoic acid | 350 mg | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support/maintain (normal) heart/cardiovascular health. Helps support/maintain brain function. Helps support/maintain cognitive health. Helps in the development and maintenance of night vision. Helps maintain/support eyesight/skin/mucous membranes/(and) immune function/the immune system Source of/Provides (an) antioxidant(s).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80139449
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.